These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 16461565)

  • 21. The survival effect of E-cadherin and catenins in colorectal carcinomas.
    Filiz AI; Senol Z; Sucullu I; Kurt Y; Demirbas S; Akin ML
    Colorectal Dis; 2010 Dec; 12(12):1223-30. PubMed ID: 19575736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significant correlations of E-cadherin, catenin, and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas.
    Mikami T; Saegusa M; Mitomi H; Yanagisawa N; Ichinoe M; Okayasu I
    Am J Clin Pathol; 2001 Sep; 116(3):369-76. PubMed ID: 11554165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of E-cadherin, alpha-, beta- and gamma-catenin in bladder cancer patients who underwent radical cystectomy.
    Kashibuchi K; Tomita K; Schalken JA; Kume H; Takeuchi T; Kitamura T
    Int J Urol; 2007 Sep; 14(9):789-94. PubMed ID: 17760743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological relevance of E-cadherin-catenin complex proteins in primary epithelial ovarian tumours.
    Faleiro-Rodrigues C; Macedo-Pinto IM; Maia SS; Vieira RH; Lopes CS
    Gynecol Obstet Invest; 2005; 60(2):75-83. PubMed ID: 15785075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma.
    Ramasami S; Kerr KM; Chapman AD; King G; Cockburn JS; Jeffrey RR
    J Pathol; 2000 Dec; 192(4):427-32. PubMed ID: 11113858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis.
    Hirata K; Ajiki T; Okazaki T; Horiuchi H; Fujita T; Kuroda Y
    Oncology; 2006; 71(1-2):102-10. PubMed ID: 17341890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
    Schlosshauer PW; Ellenson LH; Soslow RA
    Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical alpha- and beta-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma.
    Nozawa N; Hashimoto S; Nakashima Y; Matsuo Y; Koga T; Sugio K; Niho Y; Harada M; Sueishi K
    Pathol Res Pract; 2006; 202(9):639-50. PubMed ID: 16843618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
    Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
    Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival.
    Kayastha S; Freedman AN; Piver MS; Mukkamalla J; Romero-Guittierez M; Werness BA
    Clin Cancer Res; 1999 May; 5(5):1073-6. PubMed ID: 10353740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant expression of beta- and gamma-catenin is an independent prognostic marker in oral squamous cell carcinoma.
    Ueda G; Sunakawa H; Nakamori K; Shinya T; Tsuhako W; Tamura Y; Kosugi T; Sato N; Ogi K; Hiratsuka H
    Int J Oral Maxillofac Surg; 2006 Apr; 35(4):356-61. PubMed ID: 16288849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
    Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ
    Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
    Lim SC; Lee MS
    Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E-cadherin and catenins in early squamous cervical carcinoma.
    Van de Putte G; Kristensen GB; Baekelandt M; Lie AK; Holm R
    Gynecol Oncol; 2004 Aug; 94(2):521-7. PubMed ID: 15297198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables.
    Rosado P; Lequerica-Fernández P; Fernández S; Allonca E; Villallaín L; de Vicente JC
    Br J Oral Maxillofac Surg; 2013 Mar; 51(2):149-56. PubMed ID: 22525043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E-Cadherin complex protein expression and survival in ovarian carcinoma.
    Davidson B; Gotlieb WH; Ben-Baruch G; Nesland JM; Bryne M; Goldberg I; Kopolovic J; Berner A
    Gynecol Oncol; 2000 Dec; 79(3):362-71. PubMed ID: 11104606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of E-cadherin in patients with advanced serous ovarian cancer.
    Bačić B; Haller H; Mrklić I; Košta V; Čarić A; Tomić S
    Arch Gynecol Obstet; 2013 Jun; 287(6):1219-24. PubMed ID: 23269354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
    Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y
    Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
    Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY
    Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.